Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0) unresectable non-small cell lung cancer: the Toronto experience-Reference-Cited by-同舟云学术

Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0) unresectable non-small cell lung cancer: the Toronto experience

Published:1993-03 Issue:1-6 Volume:9 Page:377-382
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Burkes Ronald L.,Ginsberg Robert J.,Shepherd Frances A.,Blackstein Martin E.,Goldberg Melvyn E.,Waters Paul F.,Alexander Patterson G.,Todd Thomas,Griffith Pearson F.,Cooper Joel D.,Jones Donald,Lockwood Gina

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference8 articles.

1. The role of surgery in N2 lung cancer;Martini;Surg Clin N Am,1987

2. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung;Pearson;Thorac Cardio Surg,1982

3. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy;Perez;Cancer,1987

4. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: a randomized trial investigating two dosage schedules;Gralla;Ann Intern Med,1981

5. Trial of the combination of mitomycin, vindesine and cisplatin in patients with advanced non-small cell lung cancer;Kris;Cancer Treat Rep,1986

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis;The Journal of Thoracic and Cardiovascular Surgery;2003-12

2. Medical complications of combined surgical and nonsurgical therapy;Current Opinion in Oncology;2000-03

3. Acute lung injury and acute respiratory distress syndrome after pulmonary resection;The Annals of Thoracic Surgery;2000-02

4. Non-Curative Surgery for Thoracic Malignancies;Focus on Cancer;1998

5. Benefits of Neoadjuvant Chemotherapy in NSCLC;Chest;1996-05